You are here
Biotech keeps rising as investors worry end is coming
BIOTECH'S days of unfettered optimism may be numbered. Since 2011, money has flowed almost non-stop into the industry as investors buy into the promise of new drugs. Signs are increasingly pointing towards an end to the boom.
One key measure of investor pessimism, the
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org